ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is DHG Pharmaceutical JSC ?
1
High Management Efficiency with a high ROE of 20.35%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 57.01
3
Poor long term growth as Net Sales has grown by an annual rate of 5.44% over the last 5 years
4
Flat results in Sep 25
- INTEREST(Q) Highest at VND 9,939.5 MM
5
With ROE of 22.34%, it has a fair valuation with a 3.50 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 3.56%, its profits have risen by 2.8% ; the PEG ratio of the company is 5.6
- At the current price, the company has a high dividend yield of 9.9
6
Underperformed the market in the last 1 year
- The stock has generated a return of 3.56% in the last 1 year, much lower than market (Vietnam VN Ho Chi Minh Index) returns of 43.59%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to DHG Pharmaceutical JSC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is DHG Pharmaceutical JSC for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
DHG Pharmaceutical JSC
-100.0%
-0.90
16.58%
Vietnam VN Ho Chi Minh Index
43.59%
1.93
22.62%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.44%
EBIT Growth (5y)
5.69%
EBIT to Interest (avg)
57.01
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
0.98
Tax Ratio
13.16%
Dividend Payout Ratio
173.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
45.64%
ROE (avg)
20.35%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.50
EV to EBIT
12.00
EV to EBITDA
10.44
EV to Capital Employed
5.38
EV to Sales
2.37
PEG Ratio
5.59
Dividend Yield
9.86%
ROCE (Latest)
44.85%
ROE (Latest)
22.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at VND 1,383,601.75 MM
RAW MATERIAL COST(Y)
Fallen by -13.12% (YoY
-7What is not working for the Company
INTEREST(Q)
Highest at VND 9,939.5 MM
Here's what is working for DHG Pharmaceutical JSC
Operating Cash Flow
Highest at VND 1,383,601.75 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (VND MM)
Raw Material Cost
Fallen by -13.12% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for DHG Pharmaceutical JSC
Interest
At VND 9,939.5 MM has Grown at 52.71%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Interest
Highest at VND 9,939.5 MM
in the last five periods and Increased by 52.71% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
